Connexins in atherosclerosis
Authors:
- Marc ChansonMCMarc Chanson
- Brenda R. KwakBKBrenda R. Kwak
- 1 January 2013
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1828 (1) , 157-166
Abstract
No abstract availableKeywords
Funding Information
- Swiss National Science Foundation (310030‐127551, 310000‐119739)
- Swiss National Science Foundation
- Swiss Academy of Medical Sciences
- Velux Foundation (323630‐123735)
This publication has 111 references indexed in Scilit:
- How dendritic cells shape atherosclerosisTrends in Immunology, 2011
- Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothoraxDevelopmental Biology, 2011
- Intraplaque haemorrhages as the trigger of plaque vulnerabilityEuropean Heart Journal, 2011
- Modulatory effects of connexin‐43 expression on gap junction intercellular communications with mast cells and fibroblastsJournal of Cellular Biochemistry, 2011
- GJC2 Missense Mutations Cause Human LymphedemaThe American Journal of Human Genetics, 2010
- An angiotensin II- and NF-κB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertensionCardiovascular Research, 2010
- Connexin 37 profoundly slows cell cycle progression in rat insulinoma cellsAmerican Journal of Physiology-Cell Physiology, 2008
- Cyclic adenosine monophosphate is a key component of regulatory T cell–mediated suppressionJournal of Experimental Medicine, 2007
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Gap junctions: structure and function (Review)Molecular Membrane Biology, 2002